Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor-tezacaftor-ivacaftor, Germany, 2012-2021

Eur Respir J. 2023 Jan 12;61(1):2201402. doi: 10.1183/13993003.01402-2022. Print 2023 Jan.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Cystic Fibrosis* / drug therapy
  • Cystic Fibrosis* / genetics
  • Humans
  • Lung Transplantation*
  • Mutation

Substances

  • elexacaftor
  • ivacaftor
  • tezacaftor
  • Cystic Fibrosis Transmembrane Conductance Regulator